论文信息 - Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019) - 字舞流文

Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)

D. Teachey | S. Grupp | D. Porter | B. Levine | C. June | J. Melenhorst | P. Shaw | C. Callahan | S. Maude | P. Wood | D. Barrett | R. Aplenc | S. Lacey | S. Rheingold | L. Motley